Evidence map›Paper›PMID 26149666›Full record

ArticleBMC medicine2015

CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so.

Jingling Zhou, Gaoqian Feng, James Beeson, P Mark Hogarth, Stephen J Rogerson, Yan Yan, Anthony Jaworowski

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Differential Effect of Extracellular Vesicles Derived fromInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Mediterranean Diet: Lipids, Inflammation, and Malaria Infection.International journal of molecular sciences · 2020
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Monocyte-derived dendritic cells in malaria.Current opinion in microbiology · 2019
    Review
  19. Article
  20. NK cells inhibiteLife · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jingling ZhouCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia. jingling@burnet.edu.au.
Gaoqian FengCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia. feng@burnet.edu.au.
James BeesonCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia. beeson@burnet.edu.au.
P Mark HogarthCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia. pmhogarth@burnet.edu.au.
Stephen J RogersonDepartment of Medicine, University of Melbourne, Melbourne, Victoria, 3050, Australia. sroger@unimbelb.edu.au.
Yan YanDepartment of Chemical and Biomolecular Engineering, University of Melbourne, Melbourne, Victoria, 3800, Australia. yanyan@unimelb.edu.au.
Anthony JaworowskiCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia. anthonyj@burnet.edu.au.
Burnet Institute · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith more than 600,000 deaths from malaria, mainly of children under five years old and caused by infection with Plasmodium falciparum, comes an urgent need for an effective anti-malaria vaccine. Limited details on the mechanisms of protective immunity are a barrier to vaccine development. Antibodies play an important role in immunity to malaria and monocytes are key effectors in antibody-mediated protection by phagocytosing antibody-opsonised infected erythrocytes (IE). Eliciting antibodies that enhance phagocytosis of IE is therefore an important potential component of an effective vaccine, requiring robust assays to determine the ability of elicited antibodies to stimulate this in vivo. The mechanisms by which monocytes ingest IE and the nature of the monocytes which do so are unknown.

methodsPurified trophozoite-stage P. falciparum IE were stained with ethidium bromide, opsonised with anti-erythrocyte antibodies and incubated with fresh whole blood. Phagocytosis of IE and TNF production by individual monocyte subsets was measured by flow cytometry. Ingestion of IE was confirmed by imaging flow cytometry.

resultsCD14(hi)CD16+ monocytes phagocytosed antibody-opsonised IE and produced TNF more efficiently than CD14(hi)CD16- and CD14(lo)CD16+ monocytes. Blocking experiments showed that Fcγ receptor IIIa (CD16) but not Fcγ receptor IIa (CD32a) or Fcγ receptor I (CD64) was necessary for phagocytosis. CD14(hi)CD16+ monocytes ingested antibody-opsonised IE when peripheral blood mononuclear cells were reconstituted with autologous serum but not heat-inactivated autologous serum. Antibody-opsonised IE were rapidly opsonised with complement component C3 in serum (t1/2 = 2-3 minutes) and phagocytosis of antibody-opsonised IE was inhibited in a dose-dependent manner by an inhibitor of C3 activation, compstatin. Compared to other monocyte subsets, CD14(hi)CD16+ monocytes expressed the highest levels of complement receptor 4 (CD11c) and activated complement receptor 3 (CD11b) subunits.

conclusionsWe show a special role for CD14(hi)CD16+ monocytes in phagocytosing opsonised P. falciparum IE and production of TNF. While ingestion was mediated by Fcγ receptor IIIa, this receptor was not sufficient to allow phagocytosis; despite opsonisation with antibody, phagocytosis of IE also required complement opsonisation. Assays which measure the ability of vaccines to elicit a protective antibody response to P. falciparum should consider their ability to promote phagocytosis and fix complement.

Indexed as

Malaria, FalciparumAntibodies, ProtozoanCells, CulturedErythrocytesFlow CytometryHumansLeukocytes, MononuclearLipopolysaccharide ReceptorsMonocytesPhagocytosisPlasmodium falciparumReceptors, IgGAntibodies, ProtozoanFCGR3A protein, humanLipopolysaccharide ReceptorsReceptors, IgG

Identifiers

PMID26149666
PMCPMC4493812
OpenAlexW4233474276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.